Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

oclacitinib

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Oclacitinib is a selective Janus kinase inhibitor for the treatment of canine allergic pruritus and atopic dermatitis… Expand
  • table 1
Is this relevant?
2017
2017
&NA; The janus kinase‐inhibitor oclacitinib is licensed for the control of pruritus associated with allergic skin diseases in… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
The prevalence of allergic skin disorders has increased rapidly, and development of therapeutic agents to alleviate the symptoms… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BackgroundIn 2010, the International Task Force on Canine Atopic Dermatitis (now International Committee on Allergic Diseases of… Expand
  • table 1
Is this relevant?
2015
2015
Background Ciclosporin is approved for the treatment of atopic dermatitis (AD) in dogs and has been shown to be safe and… Expand
  • table 1
  • table 2
  • figure 1
  • table 4
  • figure 2
Is this relevant?
2015
2015
BACKGROUND Oclacitinib is a Janus kinase inhibitor that decreases pruritus and lesions in allergic dogs. In cats, it is able to… Expand
Is this relevant?
Highly Cited
2014
Highly Cited
2014
Janus kinase (JAK) enzymes are involved in cell signaling pathways activated by various cytokines dysregulated in allergy. The… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2014
2014
Background Oral glucocorticoids are widely used to reduce pruritus and dermatitis associated with allergic dermatitis. Data… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Background Pruritus is the hallmark clinical sign of atopic dermatitis (AD) in dogs. Preliminary study results suggest that… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Background Oclacitinib (Apoquel®) inhibits the function of a variety of pro-inflammatory, pro-allergic and pruritogenic cytokines… Expand
  • figure 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
Is this relevant?